Priv.-Doz. Dipl.-Ing. Gilbert Hangel, PhD
Department of Biomedical Imaging and Image-guided Therapy, Department of Neurosurgery
Position: Research Associate (Postdoc)
ORCID: 0000-0002-3986-3159
T +43 1 40400 64710
Keywords
Functional Magnetic Resonance; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Ultrahigh field MRI
Research group(s)
- High Field Magnetic Resonance Imaging and Spectroscopy
Research Area: musculoskeletal MR; neuroimaging; metabolic MR imaging and spectroscopy
Members: - intraoperative MRI
Head: Gilbert Hangel
Research Area: Development, optimisation and application of advanced MRI methods (morphological, functional, metabolic) for intraoperative MRI devices
Members: - Molecular Magnetic Resonance Imaging
Head: Wolfgang Bogner
Research Area: Development and clinical evaluation of Molecular Magnetic Resonance Imaging techniques at high (3T) and ultra-high (7T) human whole-body MR scanners
Members: - Hangel Lab
Head: Gilbert Hangel
Research Area: 7T MRI, 7T MRSI, MRI of epilepsy, MRI of brain tumours, intraoperative MRI
Members:
Research interests
- Magnetic Resonance Spectroscopic Imaging (MRSI)
- Intraoperative MRI
- MR Sequence design and development
- Ultra-high field MR
- MRI and MRSI applications to diseases of the brain (glioma, MS, epilepsy...)
Techniques, methods & infrastructure
- High resolution and ultra-high resolution MRSI of the brain at 7 T
- Non-Cartesian MRSI at 3 T and 7 T
- MRSI application to patient studies
- Intraoperative MRI
- Advanced MRI protocols for brain tumours
- MRI of epilepsy
Grants
- EPICONN (2025)
Source of Funding: LBG (Ludwig Boltzmann Gesellschaft), Klinische Forschungsgruppen
Coordinator of the collaborative project - MRSI-VSC (2024)
Source of Funding: FWF (Austrian Science Fund), Schrödinger
Principal Investigator - Hochauflösende neurochemische Epilepsie-Bildgebung (2022)
Source of Funding: FWF (Austrian Science Fund), Klinische Forschung
Principal Investigator - QTIME - Quantitatives 7T MRSI in Tumoren (2022)
Source of Funding: FWF (Austrian Science Fund), Klinische Forschung
Principal Investigator - 3D 2HG Bildgebung als Biomarker für IDH-Mutation in Gliomen (2017)
Source of Funding: FWF (Austrian Science Fund), Programme Clinical Research
Principal Investigator
Selected publications
- Hangel, G. et al. (2018) ‘Ultra-high resolution brain metabolite mapping at 7 T by short-TR Hadamard-encoded FID-MRSI’, NeuroImage, 168, pp. 199–210. Available at: http://dx.doi.org/10.1016/j.neuroimage.2016.10.043.
- Hangel, G. et al. (2015) ‘Lipid suppression via double inversion recovery with symmetric frequency sweep for robust 2D‐GRAPPA‐accelerated MRSI of the brain at 7 T’, NMR in Biomedicine, 28(11), pp. 1413–1425. Available at: http://dx.doi.org/10.1002/nbm.3386.
- Hangel, G. et al. (2023) ‘Advanced<scp>MR</scp>Techniques for Preoperative Glioma Characterization: Part 2’, Journal of Magnetic Resonance Imaging, 57(6), pp. 1676–1695. Available at: https://doi.org/10.1002/jmri.28663.
- Hangel, G. et al. (2022) ‘7T HR FID-MRSI Compared to Amino Acid PET: Glutamine and Glycine as Promising Biomarkers in Brain Tumors’, Cancers, 14(9), p. 2163. Available at: https://doi.org/10.3390/cancers14092163.
- Hangel, G. et al. (2023) ‘Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation’, Journal of Neurology, 271(2), pp. 804–818. Available at: https://doi.org/10.1007/s00415-023-11988-5.